Hepatitis C in pregnancy

Grace L Su1

  • 1Department of Internal Medicine, University of Michigan Medical School, 1510C MSRB I, Box 0666, 1150 West Medical Center Drive, Ann Arbor, MI 48109, USA. gsu@umich.edu

Insights

Hepatitis C in pregnant women poses unique challenges, impacting maternal treatment decisions and risking mother-to-child transmission. Identifying transmission risks and prevention strategies is crucial for maternal and infant health.

Area of Science:

  • Hepatology
  • Maternal-Fetal Medicine
  • Virology

Background:

  • Hepatitis C is a significant global health concern affecting diverse populations.
  • Pregnancy introduces unique complexities to managing Hepatitis C in women.
  • Hepatitis C virus (HCV) infection in pregnant women necessitates specialized considerations for both maternal and infant well-being.

Purpose of the Study:

  • To highlight the distinct challenges posed by Hepatitis C in pregnant women.
  • To underscore the impact of pregnancy on Hepatitis C treatment and medical decisions.
  • To emphasize the critical need for understanding and preventing mother-to-child transmission of Hepatitis C.

Main Methods:

  • This abstract focuses on the clinical implications and transmission dynamics of Hepatitis C in pregnancy.
  • It reviews the unique considerations for therapeutic and medical management during pregnancy.
  • It addresses the risks and concerns related to vertical transmission from mother to child.

Main Results:

  • Pregnancy significantly influences therapeutic and medical management choices for Hepatitis C.
  • Mother-to-child transmission of Hepatitis C is a key concern during pregnancy.
  • Further research is needed to identify specific risk factors for transmission.

Conclusions:

  • Hepatitis C in pregnant women requires careful management due to pregnancy-related factors.
  • Preventing mother-to-child transmission of Hepatitis C is a primary objective.
  • Identifying risk factors is essential for effective prevention strategies.

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...